Not Yet Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm
NCT07078357
Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor (StreptInCorVac)
Phase I/IIa Clinical Trial to Evaluate the Safety and Immunogenicity of StreptInCor, a Synthetic Vaccine Against Streptococcus Pyogenes, in Healthy Adult Volunteers.
Sponsor: University of Sao Paulo General Hospital
Conditions
Rheumatic Diseases Rheumatic Heart Disease Rheumatic Heart Disease in Children Vaccine Vaccine Acceptance Vaccine Adverse Reaction
Interventions
Placebo StrepIncor
Updated 1 time since 2025 Last updated: Jul 17, 2025 Started: Oct 1, 2025 Primary completion: Oct 1, 2027 Completion: Dec 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1/PHASE2 clinical study on Rheumatic Diseases and Rheumatic Heart Disease, this trial is actively recruiting participants. The trial is conducted by University of Sao Paulo General Hospital and has accumulated 1 data snapshot since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1/PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University of Sao Paulo General Hospital
Data source: University of Sao Paulo General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .